Sciety invests in life science and digital health companies with the potential to become market leaders and drive meaningful change. They focus on companies in the Nordic region and utilize a rigorous selection process grounded in deep industry expertise. Their investment engagement is long-term, emphasizing active ownership as a key to creating value for both the companies and the investors. Sciety aims to capitalize on the increasing demand for drugs, innovative medical technology, and digital solutions driven by factors such as an aging population, increasing lifestyle diseases, and more demanding healthcare consumers. They also note the opportunities stemming from the biotechnological revolution in areas such as precision medicine and genomics. Sciety Venture Partners brings together experienced investors, from private investment firms and family offices to specialised investment companies, with a strong track record. They actively co-invest with Nordic and European venture capital and corporate venture capital firms.
Bevorzugte Reifephase für die erste Finanzierung.
Life Science, Digital Health, Drugs, Medical Technology, Digital Solutions, Precision Medicine, Genomics
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
